• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜和铜配合物与氟喹诺酮类抗生素的膦衍生物 - 细胞毒性作用模式的比较研究。

Cu and Cu complexes with phosphine derivatives of fluoroquinolone antibiotics - A comparative study on the cytotoxic mode of action.

机构信息

Faculty of Chemistry, University of Wroclaw, Joliot-Curie 14, 50-383 Wroclaw, Poland.

Faculty of Chemistry, University of Wroclaw, Joliot-Curie 14, 50-383 Wroclaw, Poland.

出版信息

J Inorg Biochem. 2018 Apr;181:1-10. doi: 10.1016/j.jinorgbio.2018.01.008. Epub 2018 Jan 9.

DOI:10.1016/j.jinorgbio.2018.01.008
PMID:29348049
Abstract

In this paper, we present a comparative study on the cytotoxic mode of action of copper(I) and copper(II) complexes with phosphine derivatives of fluoroquinolone antibiotics (ciprofloxacin HCp and norfloxacin HNr). The in vitro cytotoxic activity of four new compounds was tested against two selected cancer cell lines. All complexes exhibited much better cytotoxicity against both cell lines than unmodified fluoroquinolone antibiotics, their phosphines (PCp, PNr), chalcogenide derivatives (oxides: OPCp, OPNr; sulfides: SPCp, SPNr and selenides: SePCp, SePNr) and previously described by us complexes with phosphines derived from different fluoroquinolones: lomefloxacin (HLm) and sparfloxacin (HSf) as well as cisplatin. Apoptosis, observed at a great predominance, was induced by all studied complexes. Importantly, it was concluded that coordination compounds with Cu(I) ion ([Cu-PNr] and [Cu-PCp]) were much more active than those with Cu(II) ion ([OPNr-Cu], [OPCp-Cu]), even though the highest efficacy to produce reactive oxygen species, participating in overall cytotoxicity, was proved for copper(II) complexes among all studied compounds. Herein, we discuss not only results obtained for copper(I)/(II) complexes with phosphines derived from HNr and HCp but we also compare them to previously described data for complexes with HLm and HSf derivatives. This is the first insight into a structure-activity relationship of copper complexes with phosphine derivatives of fluoroquinolone antibiotics.

摘要

在本文中,我们对铜(I)和铜(II)配合物与氟喹诺酮类抗生素(环丙沙星 HCP 和诺氟沙星 HNR)的膦衍生物的细胞毒性作用模式进行了比较研究。四种新化合物的体外细胞毒性活性针对两种选定的癌细胞系进行了测试。所有配合物对两种细胞系的细胞毒性均明显优于未修饰的氟喹诺酮类抗生素、其膦(PCp、PNr)、硫属元素衍生物(氧化物:OPCp、OPNr;硫化物:SPCp、SPNr 和硒化物:SePCp、SePNr)以及我们之前描述的由不同氟喹诺酮类抗生素衍生的膦配合物:洛美沙星(HLm)和司帕沙星(HSf)以及顺铂。观察到的凋亡在很大程度上是由所有研究的配合物诱导的。重要的是,得出结论,与 Cu(II)离子([OPNr-Cu]、[OPCp-Cu])配位的配合物比与 Cu(I)离子([Cu-PNr]和[Cu-PCp])配位的配合物活性更高,尽管所有研究化合物中铜(II)配合物被证明具有产生参与总体细胞毒性的活性氧物种的最高功效。在这里,我们不仅讨论了源自 HNr 和 HCp 的膦衍生物的铜(I)/(II)配合物的结果,还将它们与先前描述的 HLm 和 HSf 衍生物配合物的数据进行了比较。这是首次深入研究铜配合物与氟喹诺酮类抗生素的膦衍生物的结构-活性关系。

相似文献

1
Cu and Cu complexes with phosphine derivatives of fluoroquinolone antibiotics - A comparative study on the cytotoxic mode of action.铜和铜配合物与氟喹诺酮类抗生素的膦衍生物 - 细胞毒性作用模式的比较研究。
J Inorg Biochem. 2018 Apr;181:1-10. doi: 10.1016/j.jinorgbio.2018.01.008. Epub 2018 Jan 9.
2
Antibacterial activity and action mode of Cu(I) and Cu(II) complexes with phosphines derived from fluoroquinolone against clinical and multidrug-resistant bacterial strains.含膦配体的 Cu(I)和 Cu(II)配合物的抗菌活性和作用模式及其对临床和多药耐药菌的抑制作用。
J Inorg Biochem. 2020 Sep;210:111124. doi: 10.1016/j.jinorgbio.2020.111124. Epub 2020 Jun 2.
3
Copper(I) complexes with phosphine derived from sparfloxacin. Part II: a first insight into the cytotoxic action mode.铜(I)与源自司帕沙星的膦的配合物。第二部分:对细胞毒性作用模式的初步见解。
Dalton Trans. 2016 Mar 28;45(12):5052-63. doi: 10.1039/c5dt04011f.
4
Copper(i) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(i) complexes.与来源于司帕沙星的膦配合的铜(I)配合物。第三部分:多方面的细胞死亡和选定铜(I)配合物的脂质体制剂的初步研究。
Dalton Trans. 2018 Feb 6;47(6):1981-1992. doi: 10.1039/c7dt03917d.
5
Copper(i) complexes with phosphine derived from sparfloxacin. Part I - structures, spectroscopic properties and cytotoxicity.铜(I)与源自司帕沙星的膦的配合物。第一部分——结构、光谱性质和细胞毒性。
Dalton Trans. 2015 Jul 28;44(28):12688-99. doi: 10.1039/c5dt01146a.
6
Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.中性和带电膦/硫代羧酸铜(I)配合物:配体组装对其抗增殖活性的影响。
Eur J Med Chem. 2013 Jan;59:218-26. doi: 10.1016/j.ejmech.2012.11.022. Epub 2012 Nov 23.
7
Polymeric micelle-mediated delivery of half-sandwich ruthenium(II) complexes with phosphanes derived from fluoroloquinolones for lung adenocarcinoma treatment.聚合物胶束介导的含膦氟诺喹酮衍生物的半夹心钌(II)配合物用于治疗肺腺癌细胞。
Eur J Pharm Biopharm. 2018 Jul;128:69-81. doi: 10.1016/j.ejpb.2018.04.016. Epub 2018 Apr 17.
8
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines.新型含三(2-氰乙基)膦铜(I)配合物诱导人癌细胞毒性和线粒体功能障碍。
Invest New Drugs. 2011 Dec;29(6):1213-23. doi: 10.1007/s10637-010-9466-7. Epub 2010 Jun 22.
9
Homoleptic phosphino copper(I) complexes with in vitro and in vivo dual cytotoxic and anti-angiogenic activity.具有体外和体内双重细胞毒性及抗血管生成活性的均配型膦基铜(I)配合物
Metallomics. 2015 Nov;7(11):1497-507. doi: 10.1039/c5mt00163c. Epub 2015 Jul 20.
10
Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.含新型双(1,2,4 - 三唑 - 1 - 基)乙酸酯配体的三(羟甲基)膦铜(I)配合物的合成、表征及体外抗肿瘤性能
J Med Chem. 2006 Dec 14;49(25):7317-24. doi: 10.1021/jm0601248.

引用本文的文献

1
Recent Development of Fluoroquinolone Derivatives as Anticancer Agents.氟喹诺酮衍生物类抗癌药物的最新研究进展。
Molecules. 2024 Jul 27;29(15):3538. doi: 10.3390/molecules29153538.
2
ROS-producing nanomaterial engineered from Cu(I) complexes with PN-ligands for cancer cells treating.由含PN配体的Cu(I)配合物构建的用于癌细胞治疗的产ROS纳米材料。
Discov Nano. 2023 Oct 30;18(1):133. doi: 10.1186/s11671-023-03912-7.
3
Liposomal Binuclear Ir(III)-Cu(II) Coordination Compounds with Phosphino-Fluoroquinolone Conjugates for Human Prostate Carcinoma Treatment.
具有膦基-氟喹诺酮共轭物的脂质体双核 Ir(III)-Cu(II)配合物用于人类前列腺癌治疗。
Inorg Chem. 2022 Dec 5;61(48):19261-19273. doi: 10.1021/acs.inorgchem.2c03015. Epub 2022 Nov 16.
4
Quinolones as a Potential Drug in Genitourinary Cancer Treatment-A Literature Review.喹诺酮类药物作为泌尿生殖系统癌症治疗的潜在药物——文献综述
Front Oncol. 2022 Jun 8;12:890337. doi: 10.3389/fonc.2022.890337. eCollection 2022.
5
: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu, Ru, Ir Complexes.膦基铜、钌、铱配合物的合成、物理化学性质及生物学性质
Pharmaceuticals (Basel). 2022 Jan 29;15(2):169. doi: 10.3390/ph15020169.
6
Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells.小分子诱导非小细胞肺癌细胞 NQO1 水平升高而上调野生型 p53。
Acta Pharmacol Sin. 2022 Mar;43(3):692-702. doi: 10.1038/s41401-021-00691-8. Epub 2021 May 25.